Physician profile
Daniel G Constance
NPI 1912110578
$807.78
in general payments reported to CMS, 2019-2025
12 companies · $270 in 2025
The $270 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $18.01 · 2022: $28.00 · 2023: $33.79 · 2024: $289 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $237.51 | 2022-2025 | Stravix, Grafix, Oasis |
| Inari Medical, INC. | $155.39 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bioventus LLC | $90.82 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $77.89 | 2019-2020 | |
| Stryker Corporation | $66.96 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $37.71 | 2024 | Flexitouch Plus, Entre Plus |
| Depuy Synthes Sales INC. | $33.73 | 2019 | |
| Pylant Medical | $30.37 | 2025 | |
| Glaxosmithkline, LLC. | $27.55 | 2025 | Arexvy, Shingrix, Bexsero |
| Pacira Pharmaceuticals Incorporated | $20.63 | 2019 | |
| Averitas Pharma INC. | $18.01 | 2024 | Qutenza |
| Zyla Life Sciences, INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Constance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.